NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Stock Ownership - Who owns Corbus Pharmaceuticals Holdings?

Insider buying vs selling

Have Corbus Pharmaceuticals Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Cormorant Asset Management LPInsider2026-10-29425,000$4.10
$1.74MSell
Yong BenDirector2026-09-142,000$7.84
$15.68kSell
Nishant C. SaxenaCXO2026-08-112,600$9.63
$25.04kBuy
Yuval CohenCEO2026-08-0717,000$10.08
$171.39kSell
Sean F. MoranCFO2026-08-0712,000$10.08
$120.97kSell
Anne AltmeyerDirector2026-06-102,412$7.91
$19.09kSell
John Kenneth JenkinsDirector2026-06-104,800$7.91
$37.99kSell
Winston KungDirector2026-06-102,026$7.91
$16.03kSell
Nishant C. SaxenaChief Business Officer2026-06-039,000$7.58
$68.22kBuy
Nishant C. SaxenaChief Business Officer2026-06-024,500$7.33
$33.00kBuy

1 of 2

CRBP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBP insiders and whales buy or sell their stock.

CRBP Shareholders

What type of owners hold Corbus Pharmaceuticals Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cormorant Asset Management LP32.22%6,639,942$22.51MInsider
Sumner Burstein17.44%3,594,571$12.19MInsider
Knoll Capital Management LP13.35%2,750,000$9.32MInsider
Mark Tepper10.24%2,110,400$7.15MInsider
David P. Hochman3.97%818,700$2.78MInsider
Barbara White1.00%206,217$699.08kInsider
Yuval Cohen0.76%157,316$533.30kInsider
Dominic Smethurst0.44%89,790$304.39kInsider
Sean F. Moran0.41%84,694$287.11kInsider
Nishant C. Saxena0.38%77,900$264.08kInsider

1 of 3

CRBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBP0.03%81.53%Net SellingNet Selling
OKYO0.00%100.00%Net Buying
TLSA0.00%82.25%Net Buying
MNOV0.01%84.05%Net SellingNet Selling
GOSS0.01%99.99%

Corbus Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) is owned by 0.03% institutional shareholders, 81.53% Corbus Pharmaceuticals Holdings insiders, and 18.44% retail investors. Cormorant Asset Management LP is the largest individual Corbus Pharmaceuticals Holdings shareholder, owning 6.64M shares representing 32.22% of the company. Cormorant Asset Management LP's Corbus Pharmaceuticals Holdings shares are currently valued at $22.51M.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.